Over-the-Counter Drug Product Monographs: FDA Requirements for Hand Sanitizers and other COVID-19-focused Products

Wednesday, June 16th 2pm ET


Register for our webinar taking a look at longer term compliance requirements Post-COVID-19

Join us in a series of OTC-focused webinars featuring Reed Tech subject-matter experts and some of our industry friends and colleagues.

Our webinar on Wednesday, June 16th at 2PM ET will feature Reed Tech subject-matter expert Caitlin Osborn and Amin Talati Wasserman LLP subject-matter experts Shelly Garg and Karmina Fefferman.

As the pandemic conditions draw to a close, companies who produced pharma products, such as hand sanitizers, under the FDA temporary policy should begin looking at longer term compliance requirements.

This 30-minute webinar is designed to provide an overview of OTC regulatory requirements, key marketing issues, and FDA enforcement in this area. Join us to learn how to continue compliantly producing COVID-19-focused products once the pandemic conditions conclude.

Key Topics

  • Overview of OTC Monograph Process
  • COVID-19 Temporary Policy for Hand Sanitizers
  • OTC Monograph Requirements
  • FDA Enforcement
  • Q&A

Who should attend this webinar?

  • Compliance
  • Regulatory Affairs
  • Operations
  • Production
  • Quality Assurance 

Amin Talati Wasserman LLP focuses on regulatory compliance, intellectual property, dispute resolution and litigation. The firm represents food, beverage, dietary supplement, drug, cosmetic, and medical device companies and seeks to produce best-in-class results, strong client and professional satisfaction, and develop long-term relationships. 

Reed Tech is the provider of best-in-class information-based solutions and services to meet the needs of the life sciences industry, government agencies, and the intellectual property market. Our customers are located throughout the world and include a wide range of medical device manufacturers and pharmaceutical companies, the U.S. government, numerous Patent Authorities, and IP-driven companies and law firms. The corporate mission is to advance humanity by delivering better outcomes to the innovation community. Reed Tech is a LexisNexis company.

For more information: Pharma@ReedTech.com, +1-215-557-3010

Register Now!